The network of non-coding RNAs and their molecular targets in breast cancer.
Journal
Molecular cancer
ISSN: 1476-4598
Titre abrégé: Mol Cancer
Pays: England
ID NLM: 101147698
Informations de publication
Date de publication:
18 03 2020
18 03 2020
Historique:
received:
03
01
2020
accepted:
05
03
2020
entrez:
20
3
2020
pubmed:
20
3
2020
medline:
3
2
2021
Statut:
epublish
Résumé
Non-coding RNAs are now recognized as fundamental components of the cellular processes. Non-coding RNAs are composed of different classes, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). Their detailed roles in breast cancer are still under scrutiny. We systematically reviewed from recent literature the many functional and physical interactions of non-coding RNAs in breast cancer. We used a data driven approach to establish the network of direct, and indirect, interactions. Human curation was essential to de-convolute and critically assess the experimental approaches in the reviewed articles. To enrol the scientific papers in our article cohort, due to the short time span (shorter than 5 years) we considered the journal impact factor rather than the citation number. The outcome of our work is the formal establishment of different sub-networks composed by non-coding RNAs and coding genes with validated relations in human breast cancer. This review describes in a concise and unbiased fashion the core of our current knowledge on the role of lncRNAs, miRNAs and other non-coding RNAs in breast cancer. A number of coding/non-coding gene interactions have been investigated in breast cancer during recent years and their full extent is still being established. Here, we have unveiled some of the most important networks embracing those interactions, and described their involvement in cancer development and in its malignant progression.
Sections du résumé
BACKGROUND
Non-coding RNAs are now recognized as fundamental components of the cellular processes. Non-coding RNAs are composed of different classes, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). Their detailed roles in breast cancer are still under scrutiny.
MAIN BODY
We systematically reviewed from recent literature the many functional and physical interactions of non-coding RNAs in breast cancer. We used a data driven approach to establish the network of direct, and indirect, interactions. Human curation was essential to de-convolute and critically assess the experimental approaches in the reviewed articles. To enrol the scientific papers in our article cohort, due to the short time span (shorter than 5 years) we considered the journal impact factor rather than the citation number. The outcome of our work is the formal establishment of different sub-networks composed by non-coding RNAs and coding genes with validated relations in human breast cancer. This review describes in a concise and unbiased fashion the core of our current knowledge on the role of lncRNAs, miRNAs and other non-coding RNAs in breast cancer.
CONCLUSIONS
A number of coding/non-coding gene interactions have been investigated in breast cancer during recent years and their full extent is still being established. Here, we have unveiled some of the most important networks embracing those interactions, and described their involvement in cancer development and in its malignant progression.
Identifiants
pubmed: 32188472
doi: 10.1186/s12943-020-01181-x
pii: 10.1186/s12943-020-01181-x
pmc: PMC7079433
doi:
Substances chimiques
Antineoplastic Agents
0
Biomarkers, Tumor
0
RNA, Long Noncoding
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
61Références
Theranostics. 2018 Apr 15;8(10):2846-2861
pubmed: 29774079
Cancer Res. 2019 Jul 1;79(13):3347-3359
pubmed: 30940661
Mol Cancer. 2019 Jan 8;18(1):4
pubmed: 30621700
Nucleic Acids Res. 2018 Nov 16;46(20):10635-10648
pubmed: 30102404
Mol Ther Nucleic Acids. 2018 Sep 7;12:105-117
pubmed: 30195750
Mol Ther. 2019 Sep 4;27(9):1638-1652
pubmed: 31153828
EMBO Rep. 2016 May;17(5):648-58
pubmed: 27113763
J Exp Clin Cancer Res. 2019 Feb 14;38(1):79
pubmed: 30764831
Mol Cell. 2015 Aug 20;59(4):698-711
pubmed: 26236012
J Exp Clin Cancer Res. 2019 Feb 21;38(1):94
pubmed: 30791958
Cancer Res. 2014 Dec 15;74(24):7406-17
pubmed: 25339353
Cancer Cell. 2018 Mar 12;33(3):368-385.e7
pubmed: 29455928
Elife. 2018 Mar 21;7:
pubmed: 29560860
Nat Commun. 2015 Apr 29;6:6966
pubmed: 25923108
Mol Cancer. 2017 Mar 14;16(1):62
pubmed: 28288641
J Exp Clin Cancer Res. 2017 Nov 2;36(1):153
pubmed: 29096683
Cancer Res. 2019 Apr 1;79(7):1520-1534
pubmed: 30737233
Nat Commun. 2014 Nov 19;5:5406
pubmed: 25406648
Cell Death Dis. 2017 Jan 19;8(1):e2569
pubmed: 28102845
Nat Med. 2018 Nov;24(11):1743-1751
pubmed: 30397354
Cell Death Differ. 2017 Feb;24(2):357-370
pubmed: 27886165
Cancer Res. 2016 Sep 15;76(18):5562-72
pubmed: 27402080
Mol Oncol. 2016 Jun;10(6):838-49
pubmed: 26949125
Cancer Lett. 2018 Aug 28;430:179-192
pubmed: 29803789
Cell Rep. 2017 Feb 28;18(9):2256-2268
pubmed: 28249169
Cell Death Differ. 2016 Aug;23(8):1312-21
pubmed: 26915294
Stem Cells. 2019 Oct;37(10):1281-1292
pubmed: 31283068
J Exp Clin Cancer Res. 2018 Aug 29;37(1):202
pubmed: 30157918
Oncogene. 2018 Jun;37(25):3426-3439
pubmed: 29555976
Mol Oncol. 2019 Apr;13(4):909-927
pubmed: 30648789
Cancer Res. 2017 Feb 15;77(4):949-959
pubmed: 27940575
Cell Death Dis. 2018 Dec 5;9(12):1167
pubmed: 30518934
Cancer Cell. 2018 Apr 9;33(4):706-720.e9
pubmed: 29622465
Cell Oncol (Dordr). 2017 Oct;40(5):457-470
pubmed: 28741069
Cancer Res. 2015 Oct 15;75(20):4407-15
pubmed: 26359455
Cell Death Dis. 2018 Jul 24;9(8):805
pubmed: 30042378
Cell Death Dis. 2018 May 11;9(5):563
pubmed: 29752439
Theranostics. 2016 Feb 13;6(4):533-44
pubmed: 26941846
Cell Death Differ. 2018 Feb;25(2):406-420
pubmed: 29125598
Cancer Res. 2016 Sep 1;76(17):5151-62
pubmed: 27328731
Autophagy. 2017;13(11):1905-1923
pubmed: 28981380
Mol Cancer. 2019 Apr 18;18(1):89
pubmed: 30999914
Nat Commun. 2019 Mar 8;10(1):1135
pubmed: 30850595
Cancer Res. 2019 Jul 15;79(14):3608-3621
pubmed: 31118200
J Clin Invest. 2017 Sep 1;127(9):3421-3440
pubmed: 28805661
Nat Commun. 2019 Aug 22;10(1):3778
pubmed: 31439835
Nat Cell Biol. 2016 Apr;18(4):431-42
pubmed: 26999735
ACS Appl Mater Interfaces. 2018 Aug 15;10(32):26954-26963
pubmed: 30028120
PLoS Genet. 2019 May 14;15(5):e1008144
pubmed: 31086376
Theranostics. 2019 Feb 20;9(5):1401-1416
pubmed: 30867840
Nucleic Acids Res. 2017 Nov 2;45(19):11249-11267
pubmed: 28981843
Nat Commun. 2016 Sep 26;7:12791
pubmed: 27666543
Cell Res. 2016 Jun;26(6):655-73
pubmed: 27002217
Cancer Res. 2016 Mar 1;76(5):1101-11
pubmed: 26747895
Cancer Res. 2018 Sep 15;78(18):5259-5273
pubmed: 30042152
Cancer Lett. 2018 Oct 10;434:1-10
pubmed: 29969658
Mol Cell. 2015 Jul 16;59(2):243-57
pubmed: 26145175
Mol Cancer. 2014 Nov 26;13:256
pubmed: 25428807
Mol Cancer. 2017 Oct 17;16(1):161
pubmed: 29041978
Oncogene. 2018 Aug;37(34):4662-4678
pubmed: 29755127
Mol Cancer. 2018 Apr 23;17(1):83
pubmed: 29685157
Nat Cell Biol. 2017 Sep;19(9):1105-1115
pubmed: 28825698
Cancer Res. 2018 Sep 1;78(17):4915-4928
pubmed: 29945962
Mol Cancer. 2015 May 14;14:102
pubmed: 25972084
Oncogene. 2019 Jul;38(28):5612-5626
pubmed: 30967631
Nat Commun. 2015 Jun 12;6:7318
pubmed: 26065921
Genes Dev. 2016 Feb 15;30(4):386-98
pubmed: 26883358
J Hematol Oncol. 2019 Jul 24;12(1):81
pubmed: 31340867
RNA Biol. 2018 Feb 1;15(2):214-230
pubmed: 29227193
Cancer Res. 2015 Apr 15;75(8):1703-13
pubmed: 25712342
Nat Cell Biol. 2017 Jun;19(6):711-723
pubmed: 28530657
Mol Cancer. 2015 Feb 22;14:51
pubmed: 25742952
Cell Death Differ. 2018 Dec;25(12):2209-2220
pubmed: 29844570
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7392-7397
pubmed: 29941603
Theranostics. 2017 Sep 5;7(16):3920-3932
pubmed: 29109788
Cancer Res. 2018 Jul 1;78(13):3484-3496
pubmed: 29588351
Cell Rep. 2019 Jul 2;28(1):104-118.e8
pubmed: 31269432
Cancer Res. 2014 Nov 15;74(22):6648-60
pubmed: 25217527
Cell Res. 2016 Feb;26(2):217-28
pubmed: 26794868
Mol Cancer. 2015 Jan 27;14:11
pubmed: 25622979
Cancer Res. 2017 Nov 15;77(22):6168-6178
pubmed: 28935812
Mol Cancer. 2017 May 10;16(1):89
pubmed: 28490335
Cancers (Basel). 2019 Jun 08;11(6):
pubmed: 31181813
Nat Commun. 2016 Sep 19;7:12868
pubmed: 27641360
Mol Cancer. 2018 Aug 2;17(1):113
pubmed: 30068375
Theranostics. 2018 Jul 01;8(14):4003-4015
pubmed: 30083277
Cancer Res. 2014 Dec 15;74(24):7573-82
pubmed: 25368020
Nat Commun. 2019 Apr 9;10(1):1637
pubmed: 30967542
RNA Biol. 2018;15(12):1487-1498
pubmed: 30497328
Nat Genet. 2018 Dec;50(12):1705-1715
pubmed: 30349115
Proc Natl Acad Sci U S A. 2016 May 24;113(21):5898-903
pubmed: 27170187
Cell Death Dis. 2019 May 9;10(5):373
pubmed: 31073122
Cancer Res. 2018 Aug 15;78(16):4524-4532
pubmed: 29967256
Cancer Lett. 2019 May 28;450:63-75
pubmed: 30771425
Oncogene. 2017 Nov 16;36(46):6446-6461
pubmed: 28759043
Mol Cancer. 2019 Jan 8;18(1):3
pubmed: 30621694
Cancer Res. 2015 Jan 15;75(2):436-45
pubmed: 25388283
Cell Death Differ. 2016 Jan;23(1):132-45
pubmed: 26068592
Nat Commun. 2015 Jul 24;6:7743
pubmed: 26205790
Cancer Res. 2016 Nov 1;76(21):6424-6435
pubmed: 27569213
Sci Adv. 2019 Mar 06;5(3):eaat9820
pubmed: 30854423
PLoS Genet. 2018 Nov 29;14(11):e1007802
pubmed: 30496290
Nat Cell Biol. 2016 Feb;18(2):213-24
pubmed: 26751287
Nat Commun. 2014 Dec 05;5:5671
pubmed: 25476932
Aging (Albany NY). 2019 Jul 16;11(14):4858-4875
pubmed: 31310241
Cancer Res. 2017 Aug 1;77(15):4051-4064
pubmed: 28619708
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2594-E2603
pubmed: 29476008
Oncogene. 2018 Aug;37(34):4723-4734
pubmed: 29760406
Mol Oncol. 2019 May;13(5):1137-1149
pubmed: 30803129
Mol Cancer. 2015 Sep 17;14:172
pubmed: 26377202
Cancer Res. 2015 Apr 15;75(8):1580-91
pubmed: 25744716
Aging (Albany NY). 2019 Aug 10;11(15):5646-5665
pubmed: 31399552
Mol Cancer. 2018 Jan 17;17(1):9
pubmed: 29343249
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2204-2209
pubmed: 29440427
Oncogene. 2015 May 14;34(20):2609-20
pubmed: 25023702
J Natl Cancer Inst. 2019 Jul 09;:
pubmed: 31286138
Cancer Res. 2016 Dec 1;76(23):7012-7023
pubmed: 27758888
Cancer Res. 2015 Apr 1;75(7):1504-15
pubmed: 25643696
Protein Cell. 2015 Dec;6(12):881-9
pubmed: 26507842
Aging (Albany NY). 2019 Apr 14;11(7):2151-2176
pubmed: 30982780
Cell Mol Life Sci. 2019 May;76(10):2015-2030
pubmed: 30725116
Clin Epigenetics. 2019 Feb 14;11(1):29
pubmed: 30764859
J Clin Invest. 2014 Dec;124(12):5109-28
pubmed: 25401471
Theranostics. 2018 Mar 11;8(8):2251-2263
pubmed: 29721077
Mol Cancer. 2018 Jan 08;17(1):4
pubmed: 29310680
Mol Cancer. 2015 Mar 26;14:67
pubmed: 25889182
Cell Death Dis. 2019 Oct 10;10(10):764
pubmed: 31601781
Nat Cell Biol. 2017 Feb;19(2):106-119
pubmed: 28114269
Protein Cell. 2019 Aug;10(8):595-605
pubmed: 30710319
Theranostics. 2019 Oct 1;9(24):7384-7402
pubmed: 31695775
J Am Chem Soc. 2017 Feb 1;139(4):1400-1403
pubmed: 28094937
Mol Cancer. 2015 Jul 16;14:133
pubmed: 26178901
Nat Cell Biol. 2017 Mar;19(3):238-251
pubmed: 28218907
Cell Death Dis. 2016 May 26;7:e2236
pubmed: 27228351
Oncogene. 2015 Aug 20;34(34):4482-90
pubmed: 25417700
Oncogene. 2018 Aug;37(34):4750-4768
pubmed: 29765154
Cell Death Differ. 2016 Mar;23(3):484-95
pubmed: 26337669
Cell. 2014 Nov 20;159(5):1110-1125
pubmed: 25416949
J Exp Clin Cancer Res. 2019 Oct 17;38(1):418
pubmed: 31623640
Oncogene. 2019 Nov;38(47):7216-7233
pubmed: 31444414
Cancer Res. 2015 Jun 1;75(11):2375-2386
pubmed: 25840984
J Exp Clin Cancer Res. 2019 Jul 12;38(1):305
pubmed: 31300015
Cancer Res. 2018 Jan 15;78(2):501-515
pubmed: 29180477
Clin Cancer Res. 2017 Feb 15;23(4):1091-1103
pubmed: 27435395
J Hematol Oncol. 2019 Feb 22;12(1):19
pubmed: 30795783
Nat Cell Biol. 2015 Feb;17(2):183-94
pubmed: 25621950
Nat Commun. 2017 Feb 08;8:14422
pubmed: 28176758
Mol Cancer. 2018 Nov 19;17(1):160
pubmed: 30454010
Breast Cancer Res. 2018 Apr 18;20(1):32
pubmed: 29669595
Mol Cancer. 2018 Mar 6;17(1):70
pubmed: 29510731
Oncogene. 2018 Feb 22;37(8):1062-1074
pubmed: 29106390
Mol Oncol. 2017 Dec;11(12):1698-1710
pubmed: 28846832
Clin Cancer Res. 2018 Sep 1;24(17):4225-4241
pubmed: 29748184
J Am Chem Soc. 2018 Jun 6;140(22):6741-6744
pubmed: 29792692
Mol Ther. 2015 Apr;23(4):656-66
pubmed: 25531695
Cancer Res. 2016 Jan 15;76(2):293-304
pubmed: 26719542
Cell Death Differ. 2017 Jan;24(1):59-71
pubmed: 27716745
Nat Commun. 2016 Dec 20;7:13884
pubmed: 27996004
Elife. 2014 Nov 18;3:
pubmed: 25406066
Cancer Res. 2015 Sep 15;75(18):3925-35
pubmed: 26292362
Cell Death Dis. 2019 Jun 26;10(7):502
pubmed: 31243265
J Exp Clin Cancer Res. 2019 Jun 13;38(1):256
pubmed: 31196157
Theranostics. 2018 Nov 10;8(21):5801-5813
pubmed: 30613263
Mol Cancer. 2019 Jan 12;18(1):9
pubmed: 30636640
J Exp Clin Cancer Res. 2018 Nov 27;37(1):289
pubmed: 30482236
Cell Death Dis. 2019 Mar 13;10(3):248
pubmed: 30867411
Nat Commun. 2018 Nov 9;9(1):4718
pubmed: 30413718
Cancer Res. 2016 May 1;76(9):2626-36
pubmed: 27197265
Mol Cancer. 2018 Jul 16;17(1):100
pubmed: 30012170
Mol Cancer. 2019 Mar 18;18(1):42
pubmed: 30885232
Nat Commun. 2015 Apr 01;6:6716
pubmed: 25828099
J Exp Clin Cancer Res. 2017 Oct 16;36(1):145
pubmed: 29037220
Stem Cells. 2016 Jan;34(1):55-66
pubmed: 26418365
Mol Ther Nucleic Acids. 2019 Sep 6;17:138-149
pubmed: 31255976
Cancer Res. 2016 Feb 15;76(4):927-39
pubmed: 26676753
Cancer Res. 2015 Apr 1;75(7):1433-44
pubmed: 25634212
Sci Adv. 2016 Sep 02;2(9):e1600220
pubmed: 27617288
Cell Death Differ. 2019 May;26(5):843-859
pubmed: 29988076
Cancer Discov. 2015 Sep;5(9):944-59
pubmed: 26180042
Nat Cell Biol. 2017 Oct;19(10):1286-1296
pubmed: 28920955
EMBO J. 2017 Nov 15;36(22):3325-3335
pubmed: 28963395
Breast Cancer Res. 2019 Apr 3;21(1):47
pubmed: 30944027
EMBO Rep. 2017 Aug;18(8):1331-1351
pubmed: 28652379
Cell Death Dis. 2019 Aug 8;10(8):599
pubmed: 31395854
J Clin Invest. 2017 Dec 1;127(12):4498-4515
pubmed: 29130936
Cell Death Dis. 2016 Jun 09;7(6):e2262
pubmed: 27277684
Cancer Res. 2015 Jul 1;75(13):2674-85
pubmed: 25977338
Cell Death Differ. 2018 Dec;25(12):2165-2180
pubmed: 29666469
Genes Dev. 2017 Mar 15;31(6):553-566
pubmed: 28404630
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3927-3932
pubmed: 28356515
Cancer Cell. 2015 Mar 9;27(3):370-81
pubmed: 25759022
Oncogene. 2018 Nov;37(47):6166-6179
pubmed: 30002443
Theranostics. 2019 Jan 1;9(2):449-465
pubmed: 30809286
Breast Cancer Res. 2017 May 30;19(1):62
pubmed: 28558830
EMBO Rep. 2016 Apr;17(4):570-84
pubmed: 26882547
Oncogene. 2019 Mar;38(12):2020-2041
pubmed: 30467380
Cell Death Dis. 2019 May 29;10(6):423
pubmed: 31142736
Cell Death Dis. 2018 Dec 5;9(12):1171
pubmed: 30518916
Cancer Res. 2016 Mar 15;76(6):1615-26
pubmed: 26795347
Mol Cancer. 2019 Feb 11;18(1):23
pubmed: 30744636
Cancer Res. 2019 Apr 15;79(8):1784-1798
pubmed: 30622118